{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T14:26:14Z","timestamp":1787927174013,"version":"build-2784847793"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10787-026-02289-0","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T01:32:15Z","timestamp":1783042335000},"page":"5513-5523","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic evaluation of myricetin in experimental arthritis: modulation of inflammatory signaling and oxidative stress pathways"],"prefix":"10.1007","volume":"34","author":[{"given":"Iqra","family":"Ijaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasleem","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usman","family":"aftab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Naseem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Shahzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haleema","family":"Sohail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumetha","family":"Yaseen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"issue":"7","key":"2289_CR1","doi-asserted-by":"publisher","first-page":"10018","DOI":"10.1002\/jcp.27860","volume":"234","author":"M Abbasi","year":"2019","unstructured":"Abbasi M, Mousavi MJ, Jamalzehi S, Alimohammadi R, Bezvan MH, Mohammadi H, Aslani S (2019) Strategies toward rheumatoid arthritis therapy; the old and the new. J Cell Physiol 234(7):10018\u201310031","journal-title":"J Cell Physiol"},{"issue":"9","key":"2289_CR2","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.3390\/molecules27092901","volume":"27","author":"JM Al-Khayri","year":"2022","unstructured":"Al-Khayri JM, Sahana GR, Nagella P, Joseph BV, Alessa FM, Al-Mssallem MQ (2022) Flavonoids as potential anti-inflammatory molecules: a review. Molecules 27(9):2901","journal-title":"Molecules"},{"issue":"13","key":"2289_CR3","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.2018.13103","volume":"320","author":"D Aletaha","year":"2018","unstructured":"Aletaha D, Smolen JS (2018) Diagnosis and management of rheumatoid arthritis: a review. JAMA 320(13):1360\u20131372","journal-title":"JAMA"},{"issue":"1","key":"2289_CR4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/toxres\/tfad003","volume":"12","author":"A Aminzadeh","year":"2023","unstructured":"Aminzadeh A, Darijani MH, Bashiri H (2023) Investigating the effect of myricetin against arsenic-induced cardiac toxicity in rats. Toxicol Res 12(1):117\u2013123","journal-title":"Toxicol Res"},{"key":"2289_CR5","doi-asserted-by":"crossref","unstructured":"Arjumand S, Shahzad M, Shabbir A, Yousaf MZ (2019) Thymoquinone attenuates rheumatoid arthritis by downregulating TLR2, TLR4, TNF-\u03b1, IL-1, and NF\u03baB expression levels. Biomed Pharmacother 11:1958\u2013111963","DOI":"10.1016\/j.biopha.2019.01.006"},{"issue":"5","key":"2289_CR6","first-page":"594","volume":"23","author":"M Bahaloo","year":"2020","unstructured":"Bahaloo M, Rezvani ME, Yazd EF, Mehrjerdi FZ, Davari MH, Roohbakhsh A, Mollasadeghi A, Nikkhah H, Vafaei M, Mehrparvar AH (2020) Effect of myricetin on the gene expressions of NOX3, TGF-\u03b21, prestin, and HSP-70 and anti-oxidant activity in the cochlea of noise-exposed rats. Iran J Basic Med Sci 23(5):594","journal-title":"Iran J Basic Med Sci"},{"issue":"2","key":"2289_CR7","first-page":"87","volume":"5","author":"A Barzegar","year":"2016","unstructured":"Barzegar A (2016) Antioxidant activity of polyphenolic myricetin in vitro cell- free and cell-based systems. Mol biology Res Commun 5(2):87\u201395","journal-title":"Mol biology Res Commun"},{"issue":"1","key":"2289_CR8","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s13075-024-03452-0","volume":"26","author":"T Dixit","year":"2024","unstructured":"Dixit T, Vaidya A, Ravindran S (2024) Therapeutic potential of antibody-drug conjugates possessing bifunctional anti-inflammatory action in the pathogenies of rheumatoid arthritis. Arthritis Res Therapy 26(1):216","journal-title":"Arthritis Res Therapy"},{"key":"2289_CR9","doi-asserted-by":"crossref","unstructured":"Fan S, Gao X, Chen P, Li X (2018) Myricetin ameliorates glucocorticoid-induced osteoporosis through the ERK signaling pathway. Life Sci 20:7205\u2013207211","DOI":"10.1016\/j.lfs.2018.06.006"},{"issue":"1","key":"2289_CR10","first-page":"3830212","volume":"2020","author":"Q Fang","year":"2020","unstructured":"Fang Q, Zhou C, Nandakumar KS (2020) Molecular and cellular pathways contributing to joint damage in rheumatoid arthritis. Mediat Inflamm 2020(1):3830212","journal-title":"Mediat Inflamm"},{"key":"2289_CR11","doi-asserted-by":"crossref","unstructured":"Fonseca LJSD, Nunes-Souza V, Goulart MOF, Rabelo LA (2019) Oxidative stress in rheumatoid arthritis: What the future might hold regarding novel biomarkers and add-on therapies. Oxidat Med Cell Longev 2019(1): 7536805","DOI":"10.1155\/2019\/7536805"},{"issue":"10","key":"2289_CR12","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1055\/a-1224-3625","volume":"70","author":"G Gupta","year":"2020","unstructured":"Gupta G, Siddiqui MA, Khan MM, Ajmal M, Ahsan R, Rahaman MA, Ahmad MA, Arshad M, Khushtar M (2020) Current pharmacological trends on myricetin. Drug Res 70(10):448\u2013454","journal-title":"Drug Res"},{"issue":"6","key":"2289_CR13","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1136\/annrheumdis-2020-219247","volume":"80","author":"S Hayer","year":"2021","unstructured":"Hayer S, Vervoordeldonk MJ, Denis MC, Armaka M, Hoffmann M, B\u00e4cklund J, Nandakumar KS, Niederreiter B, Geka C, Fischer A (2021) SMASH\u2019recommendations for standardised microscopic arthritis scoring of histological sections from inflammatory arthritis animal models. Ann Rheum Dis 80(6):714\u2013726","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"2289_CR14","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1002\/ptr.7672","volume":"37","author":"M Israr","year":"2023","unstructured":"Israr M, Naseem N, Akhtar T, Aftab U, Zafar MS, Faheem MA, Shahzad M (2023) Nimbolide attenuates complete Freund\u2019s adjuvant induced arthritis through expression regulation of toll-like receptors signaling pathway. Phytother Res 37(3):903\u2013912","journal-title":"Phytother Res"},{"issue":"1","key":"2289_CR15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12935-022-02663-2","volume":"22","author":"Z Javed","year":"2022","unstructured":"Javed Z, Khan K, Herrera-Bravo J, Naeem S, Iqbal MJ, Raza Q, Sadia H, Raza S, Bhinder M, Calina D (2022) Myricetin: targeting signaling networks in cancer and its implication in chemotherapy. Cancer Cell Int 22(1):239","journal-title":"Cancer Cell Int"},{"issue":"3","key":"2289_CR16","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1007\/s10787-024-01445-8","volume":"32","author":"C Kaur","year":"2024","unstructured":"Kaur C, Mishra Y, Kumar R, Singh G, Singh S, Mishra V, Tambuwala MM (2024) Pathophysiology, diagnosis, and herbal medicine-based therapeutic implication of rheumatoid arthritis: an overview. Inflammopharmacology 32(3):1705\u20131720","journal-title":"Inflammopharmacology"},{"issue":"20","key":"2289_CR17","doi-asserted-by":"publisher","first-page":"10922","DOI":"10.3390\/ijms222010922","volume":"22","author":"N Kondo","year":"2021","unstructured":"Kondo N, Kuroda T, Kobayashi D (2021) Cytokine networks in the pathogenesis of rheumatoid arthritis. Int J Mol Sci 22(20):10922","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2289_CR18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.imr.2017.11.002","volume":"7","author":"HJ Mahdi","year":"2018","unstructured":"Mahdi HJ, Khan NaK, Asmawi MZB, Mahmud R, Vikneswaran A, Murugaiyah L (2018) In vivo anti-arthritic and anti-nociceptive effects of ethanol extract of Moringa oleifera leaves on complete Freund\u2019s adjuvant (CFA)-induced arthritis in rats. Integr Med Res 7(1):85\u201394","journal-title":"Integr Med Res"},{"issue":"6","key":"2289_CR19","doi-asserted-by":"publisher","first-page":"4699","DOI":"10.1007\/s11033-020-05481-9","volume":"47","author":"V Maksimovic","year":"2020","unstructured":"Maksimovic V, Pavlovic-Popovic Z, Vukmirovic S, Cvejic J, Mooranian A, Al-Salami H, Mikov M, Golocorbin-Kon S (2020) Molecular mechanism of action and pharmacokinetic properties of methotrexate. Mol Biol Rep 47(6):4699\u20134708","journal-title":"Mol Biol Rep"},{"issue":"9","key":"2289_CR20","doi-asserted-by":"publisher","first-page":"102617","DOI":"10.1016\/j.autrev.2020.102617","volume":"19","author":"P Migliorini","year":"2020","unstructured":"Migliorini P, Italiani P, Pratesi F, Puxeddu I, Boraschi D (2020) The IL-1 family cytokines and receptors in autoimmune diseases. Autoimmun rev 19(9):102617","journal-title":"Autoimmun rev"},{"key":"2289_CR21","doi-asserted-by":"crossref","unstructured":"Naz R, Ahmed Z, Shahzad M, Shabbir A, Kamal F (2020) Amelioration of rheumatoid arthritis by Anacardium occidentale via inhibition of collagenase and lysosomal enzymes. Evid Complement Alternat Med 2020(1): 8869484","DOI":"10.1155\/2020\/8869484"},{"key":"2289_CR22","doi-asserted-by":"crossref","unstructured":"Niisato N, Marunaka Y (2023) Therapeutic potential of multifunctional myricetin for treatment of type 2 diabetes mellitus. Front Nutr 10:1175660","DOI":"10.3389\/fnut.2023.1175660"},{"issue":"10","key":"2289_CR23","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.3390\/biology12101320","volume":"12","author":"F Orsini","year":"2023","unstructured":"Orsini F, Crotti C, Cincinelli G, Di Taranto R, Amati A, Ferrito M, Varenna M, Caporali R (2023) Bone involvement in rheumatoid arthritis and spondyloartritis: an updated review. Biology 12(10):1320","journal-title":"Biology"},{"issue":"15","key":"2289_CR24","doi-asserted-by":"publisher","first-page":"5238","DOI":"10.3390\/ijms21155238","volume":"21","author":"F Pandolfi","year":"2020","unstructured":"Pandolfi F, Franza L, Carusi V, Altamura S, Andriollo G, Nucera E (2020) Interleukin-6 in rheumatoid arthritis. Int J Mol Sci 21(15):5238","journal-title":"Int J Mol Sci"},{"issue":"9","key":"2289_CR25","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11926-020-00933-4","volume":"22","author":"D Poudel","year":"2020","unstructured":"Poudel D, George MD, Baker JF (2020) The impact of obesity on disease activity and treatment response in rheumatoid arthritis. Curr Rheumatol Rep 22(9):56","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"2289_CR26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11010-022-04492-3","volume":"478","author":"P Prasad","year":"2023","unstructured":"Prasad P, Verma S, Surbhi, Ganguly NK, Chaturvedi V, Mittal SA (2023) Rheumatoid arthritis: advances in treatment strategies. Mol Cell Biochem 478(1):69\u201388","journal-title":"Mol Cell Biochem"},{"issue":"11","key":"2289_CR27","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.3390\/cells10112857","volume":"10","author":"A-F Radu","year":"2021","unstructured":"Radu A-F, Bungau SG (2021) Management of rheumatoid arthritis: an overview. Cells 10(11):2857","journal-title":"Cells"},{"key":"2289_CR28","doi-asserted-by":"crossref","unstructured":"Rahmani AH, Almatroudi A, Allemailem KS, Alwanian WM, Alharbi BF, Alrumaihi F, Khan AA, Almatroodi SA (2023) Myricetin: a significant emphasis on its anticancer potential via the modulation of inflammation and signal transduction pathways. Int J Mol Sci, 24(11):9665","DOI":"10.3390\/ijms24119665"},{"issue":"8","key":"2289_CR29","first-page":"6131","volume":"3","author":"T Roy","year":"2013","unstructured":"Roy T, Ghosh S (2013) Animal models of rheumatoid arthritis: correlation and usefulness with human rheumatoid arthritis. Indo Am J Pharm Res 3(8):6131\u20136142","journal-title":"Indo Am J Pharm Res"},{"issue":"2","key":"2289_CR30","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/nu8020090","volume":"8","author":"DK Semwal","year":"2016","unstructured":"Semwal DK, Semwal RB, Combrinck S, Viljoen A (2016) Myricetin: A dietary molecule with diverse biological activities. Nutrients 8(2):90","journal-title":"Nutrients"},{"issue":"7","key":"2289_CR31","doi-asserted-by":"publisher","first-page":"865","DOI":"10.2174\/1871527322666230718105358","volume":"23","author":"NK Sethiya","year":"2024","unstructured":"Sethiya NK, Ghiloria N, Srivastav A, Bisht D, Chaudhary SK, Walia V, Alam MS (2024) Therapeutic potential of myricetin in the treatment of neurological, neuropsychiatric, and neurodegenerative disorders. CNS Neurol Disord Targets-CNS Neurol Disord 23(7):865\u2013882","journal-title":"CNS Neurol Disorders-Drug Targets-CNS Neurol Disorders)"},{"key":"2289_CR38","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/j.biopha.2017.11.118","volume":"97","author":"A Shabbir","year":"2018","unstructured":"Shabbir A, Batool SA, Basheer MI, Shahzad M, Sultana K, Tareen RB, Iqbal J (2018) Ziziphora clinopodioides ameliorated rheumatoid arthritis and inflammatory paw edema in different models of acute and chronic inflammation. Biomed Pharmacother 97:1710\u20131721","journal-title":"Biomed Pharmacother"},{"key":"2289_CR39","doi-asserted-by":"publisher","first-page":"680043","DOI":"10.3389\/fphar.2021.680043","volume":"12","author":"S Shams","year":"2021","unstructured":"Shams S, Martinez JM, Dawson JR, Flores J, Gabriel M, Garcia G, Guevara A, Murray K, Pacifici N, Vargas MV (2021) The therapeutic landscape of rheumatoid arthritis: current state and future directions. Front Pharmacol 12:680043","journal-title":"Front Pharmacol"},{"issue":"3","key":"2289_CR32","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.rdc.2022.03.005","volume":"48","author":"JA Singh","year":"2022","unstructured":"Singh JA (2022) Treatment guidelines in rheumatoid arthritis. Rheumatic Dis Clin North Am 48(3):679\u2013689","journal-title":"Rheumatic Disease Clin North Am"},{"issue":"6","key":"2289_CR33","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1136\/annrheumdis-2019-216655","volume":"79","author":"JS Smolen","year":"2020","unstructured":"Smolen JS, Landew\u00e9 RB, Bijlsma JW, Burmester GR, Dougados M, Kerschbaumer A, Mcinnes IB, Sepriano A, Van Vollenhoven RF, De Wit M (2020) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis 79(6):685\u2013699","journal-title":"Ann Rheum Dis"},{"key":"2289_CR34","doi-asserted-by":"crossref","unstructured":"Song X, Tan L, Wang M, Ren C, Guo C, Yang B, Ren Y, Cao Z, Li Y, Pei J (2021) Myricetin: A review of the most recent research. Biomed Pharmacother 134:111017","DOI":"10.1016\/j.biopha.2020.111017"},{"issue":"3","key":"2289_CR35","doi-asserted-by":"publisher","first-page":"e20192048","DOI":"10.1084\/jem.20192048","volume":"217","author":"LS Taams","year":"2020","unstructured":"Taams LS (2020) Interleukin-17 in rheumatoid arthritis: Trials and tribulations. J Exp Med 217(3):e20192048","journal-title":"J Exp Med"},{"issue":"11","key":"2289_CR36","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1111\/1756-185X.12805","volume":"19","author":"\u0130 Tekeo\u011flu","year":"2016","unstructured":"Tekeo\u011flu \u0130, G\u00fcrol G, Harman H, Karake\u00e7e E, \u00c7ift\u00e7i \u0130H (2016) Overlooked hematological markers of disease activity in rheumatoid arthritis. Int J Rheum Dis 19(11):1078\u20131082","journal-title":"Int J Rheum Dis"},{"key":"2289_CR37","doi-asserted-by":"crossref","unstructured":"Wu D, Luo Y, Li T, Zhao X, Lv T, Fang G, Ou P, Li H, Luo X, Huang A (2022) Systemic complications of rheumatoid arthritis: focus on pathogenesis and treatment. Front Immunol 13:1051082","DOI":"10.3389\/fimmu.2022.1051082"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02289-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02289-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02289-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:43:52Z","timestamp":1787924632000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-026-02289-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["2289"],"URL":"https:\/\/doi.org\/10.1007\/s10787-026-02289-0","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"5 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethical Review Committee of the University of Health Sciences, Lahore, Pakistan (UHS\/REG-23\/ERC\/4197).","order":3,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}